TwinStrand Biosciences
TwinStrand Biosciences develops Duplex Sequencing technology that uses error-corrected DNA sequencing to detect ultra-low-frequency genomic variants missed by conventional next-generation sequencing. Its technology supports researchers studying applications such as residual cancer, mutation signatures and genetic toxicology, with the aim of improving human health and accelerating scientific discovery.
Facts
- HQ
- Seattle, WA, US
- Sectors
- Biotechnology Research
- Founded
- 2016 Seattle business license
- Type
- Corporation Seattle business license
- Employees
- 51–200
- Registered name
- TwinStrand Biosciences Inc Seattle business license
- Stage
- Series B
- Members see funding amounts. .
Is this your organization? Claim it
Elon Musk's Starlink swagger, SpaceX vs. the cloud giants, and Seattle’s tech universe revisited
This week: SpaceX reports its first quarter as a public company, and Elon Musk says Starlink could deliver a majority of the world's internet within a decade, leveraging production facilities in Redmond. Musk also explains the company's data center ambitions, calling terrestrial infrastructure a trivial problem next to reusable rockets. Plus: we bring two Washington tech universe posters into the studio, 17 years apart. The 2009 original turns up gems including Boeing's unlikely connection to Classmates.com, a 1990s forerunner to Facebook. The 2009 poster also brings back memories of Teledesic, the Craig McCaw venture backed by Bill Gates that tried…
Kevin Conroy Resigns from Adaptive Biotechnologies Board; Tagboard COO Tyler Singletary Steps Down; Ron Andrews Named TwinStrand CEO
Kevin Conroy resigned from the board of Adaptive Biotechnologies, and Tagboard's COO Tyler Singletary is stepping down. Additionally, Ron Andrews was named CEO of TwinStrand Biosciences, while David Meininger stepped down as CEO of Link Immunotherapeutics.
TwinStrand Biosciences CEO Jesse Salk Steps Down Amid Layoffs; Chad Brown Named Interim CEO
TwinStrand Biosciences co-founder Jesse Salk has stepped down as CEO but will remain chief scientific officer and board member, with Chad Brown named interim CEO amid reported layoffs cutting nearly 50% of the workforce at the Seattle-based gene sequencing startup. The company, founded seven years ago and backed by a $50 million Series B round in 2021, declined to comment on the layoffs.
People
-
Jesse Salk Co-founder and CEO -
Ron Andrews Executive, Chief Executive Officer and Director
Online
Questions about TwinStrand Biosciences
What is TwinStrand Biosciences?
twinstrandbio.com
Who are the people behind TwinStrand Biosciences?
Seattle Flow lists Jesse Salk (Co-founder and CEO) and Ron Andrews (Executive, Chief Executive Officer and Director) at TwinStrand Biosciences.
Who invested in TwinStrand Biosciences, and how much has it raised?
Members of Seattle Flow see TwinStrand Biosciences' funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is TwinStrand Biosciences based?
TwinStrand Biosciences is headquartered in Seattle, WA, US.
When was TwinStrand Biosciences founded?
TwinStrand Biosciences was founded in 2016.
How many people work at TwinStrand Biosciences?
TwinStrand Biosciences has 51–200 employees.